RT Journal Article
SR Electronic
T1 Stretch-activated ion channel TMEM63B associates with developmental and epileptic encephalopathies and progressive neurodegeneration
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.22.22282283
DO 10.1101/2022.11.22.22282283
A1 Vetro, Annalisa
A1 Balestrini, Simona
A1 Pelorosso, Cristiana
A1 Masi, Alessio
A1 Hambleton, Sophie
A1 Argilli, Emanuela
A1 Conti, Valerio
A1 Giubbolini, Simone
A1 Barrick, Rebekah
A1 Bergant, Gaber
A1 Writzl, Karin
A1 Bijlsma, Emilia K.
A1 Brunet, Theresa
A1 Cacheiro, Pilar
A1 Mei, Davide
A1 Devlin, Anita
A1 Hoffer, Mariëtte J.V.
A1 Machol, Keren
A1 Mannaioni, Guido
A1 Sakamoto, Masamune
A1 Menezes, Manoj P.
A1 Courtin, Thomas
A1 Sherr, Elliott
A1 Parra, Riccardo
A1 Richardson, Ruth
A1 Roscioli, Tony
A1 Scala, Marcello
A1 Stülpnagel, Celina von
A1 Smedley, Damian
A1 TMEM63B collaborators
A1 The Genomics England Research Consortium
A1 Torella, Annalaura
A1 Tohyama, Jun
A1 Koichihara, Reiko
A1 Hamada, Keisuke
A1 Ogata, Kazuhiro
A1 Suzuki, Takashi
A1 Sugie, Atsushi
A1 van der Smagt, Jasper J.
A1 van Gassen, Koen
A1 Valence, Stephanie
A1 Vittery, Emma
A1 Kato, Mitsuhiro
A1 Matsumoto, Naomichi
A1 Ratto, Gian Michele
A1 Guerrini, Renzo
YR 2022
UL http://medrxiv.org/content/early/2022/11/24/2022.11.22.22282283.abstract
AB By converting physical forces into electrical signals or triggering intracellular cascades, stretch-activated ion channels (SACs) allow the cell to respond to osmotic and mechanical stress. Knowledge of the pathophysiological mechanisms underlying associations of SACs with human disease is limited. Here we describe 16 unrelated patients, with severe early onset developmental and epileptic encephalopathy (DEE), intellectual disability, and severe motor and cortical visual impairment, associated with progressive neurodegenerative brain changes, carrying ten distinct de novo variants of TMEM63B, encoding for a highly conserved SAC. Variants were missense, including the recurrent V44M in 7/16 patients, or in-frame, and affected conserved residues located in transmembrane regions of the protein. In 12 patients, haematological abnormalities co-occurred, such as macrocytosis and haemolysis, requiring blood transfusions in some. We modelled V44M, R443H, and T481N in transfected Neuro2a cells and demonstrated leak inward cation currents across the mutated channel even in isotonic conditions, while the response to hypo-osmotic challenge was impaired, as were the Ca2+ transients generated under hypo-osmotic stimulation. Ectopic expression of the V44M and G580C variants in Drosophila resulted in early death. TMEM63B-associated DEE represents a novel clinicopathological entity in which altered cation conductivity results in a severe neurological phenotype with progressive brain damage and early onset epilepsy, associated with haematological abnormalities in most patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTuscany Region Call for Health 2018 (grant DECODE-EE); Fondazione Cassa di Risparmio di Firenze (Human Brain Optical Mapping Project); Broad Institute of MIT and Harvard Center for Mendelian Genomics (Broad CMG); National Human Genome Research Institute, the National Eye Institute, and the National Heart, Lung and Blood Institute grant UM1 HG008900; National Human Genome Research Institute grant R01 HG009141; Fondazione Telethon, Telethon Undiagnosed Diseases Program (grant GSP15001); Japan Agency for Medical Research and Development (AMED) under grant numbers JP22ek0109486, JP22ek0109549, and JP22ek0109493; Takeda Science Foundation; Australian NHMRC Centre for Research Excellence in Neurocognition (1117394) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Paediatric Ethics Committees of the Tuscany Region, ItalyI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability The data supporting the findings of this study are available within the article and/or its Supplementary material. Any additional raw data are available on request from the corresponding author.